Active Ingredient: PEGCETACOPLAN
Proprietary Name: EMPAVELI
Dosage Form; Route of Administration: SOLUTION; SUBCUTANEOUS
Strength: 1080MG/20ML (54MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N215014
Product Number: 001
Approval Date: May 14, 2021
Applicant Holder Full Name: APELLIS PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
